Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.87 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Deutsche Bank Leveraged Finance Conference Transcript

Sep 24, 2019 / 04:40PM GMT
Release Date Price: $22.02 (-2.39%)
Miles Lindsay Highsmith
Deutsche Bank AG, Research Division - MD & Research Analyst

Okay. I'd like to welcome everybody here in the room and on the webcast. Our next presenter is Bausch Health. Today, here we have Paul Herendeen, Executive Vice President and Chief Financial Officer of Bausch. I'd like to say thank you very much for being here. It's a pleasure to have you, and we appreciate your attendance and your time.

Paul S. Herendeen
Bausch Health Companies Inc. - Executive VP & CFO

Yes. Well, first, thanks, thanks for having us. I mean, this had been a great conference for us not just this year but we've been coming the last several years. And it's very important to us because it's a very important part of the capital markets to us. And thanks for the invite, always an event that we look forward to.

Questions & Answers

Miles Lindsay Highsmith
Deutsche Bank AG, Research Division - MD & Research Analyst

Thanks, Paul. So we're just going to launch into a Q&A-based session here. And I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot